What Is a Normal DHEA-S Level in Perimenopause?

What Is a Normal DHEA-S Level in Perimenopause?

For women in perimenopause, a normal DHEA-S level typically falls between 35–200 µg/dL, though many functional medicine practitioners aim for the 100–200 µg/dL range as optimal. The main caveat: labs use wide reference ranges that include post-menopausal women, which can make low-normal look acceptable when it isn't. Women with severe symptoms and values below 50 µg/dL are the clearest exception — they often see measurable gains from targeted support.

---

Why DHEA-S Matters During Perimenopause

Dehydroepiandrosterone sulfate (DHEA-S) is the sulfated, storage form of DHEA, produced primarily by the adrenal cortex. It serves as a hormonal reservoir — your body converts it on demand into estrogens, testosterone, and other androgens. This makes it especially relevant during perimenopause, when ovarian hormone output becomes erratic and the adrenals are expected to compensate.

DHEA-S peaks in your mid-20s and declines roughly 10–20% per decade after that. By the time most women reach perimenopause (typically their mid-to-late 40s), circulating DHEA-S can be 50–70% below youthful peaks. This decline doesn't happen in isolation: it tends to track alongside rising cortisol and shifting estrogen patterns, creating a hormonal environment that affects mood, energy, body composition, bone density, and libido simultaneously (Labrie et al., Journal of Steroid Biochemistry and Molecular Biology 2010; PMID: 20060047).

Unlike estradiol or progesterone, DHEA-S doesn't spike and crash cyclically — it trends downward steadily, which means symptoms related to low DHEA-S are often vague and gradual rather than dramatic. That's partly why it gets missed.

The downstream effects are broader than many clinicians appreciate. DHEA-S is a precursor to androgens including testosterone (relevant to libido, muscle mass, and bone mineral density) and to local estrogen synthesis in peripheral tissues like skin, bone, and the vaginal epithelium. When the adrenal contribution shrinks during perimenopause, peripheral tissues lose one of their last reliable estrogen sources — even before true menopause arrives. Research has specifically documented DHEA's role in supporting vaginal tissue integrity and reducing genitourinary symptoms through this intracrinology pathway (Labrie et al., Climacteric 2018; PMID: 29069920).

---

What Lab Reference Ranges Actually Mean

Standard DHEA-S reference ranges for women aged 40–60 vary by laboratory, but most look something like this:

The conventional range is derived from population distributions — it tells you where most women in that age group land, not where you function best. A 48-year-old with a DHEA-S of 38 µg/dL is technically within range at most labs, but at the very bottom of an already declining cohort. That's not the same as being hormonally supported.

The functional optimal ranges above are informed by studies that tracked symptom burden alongside DHEA-S values. A prospective analysis in the Journal of Clinical Endocrinology & Metabolism found that perimenopausal women in the lower quartile of DHEA-S had significantly greater severity of vasomotor symptoms, mood disturbance, and sexual dysfunction compared to those in the upper quartile, even when estradiol levels were similar between groups (Burger et al., J Clin Endocrinol Metab 2000; PMID: 10946892). This suggests DHEA-S carries independent predictive value for symptom burden that is not fully captured by looking at estradiol alone.

It's also worth noting that DHEA-S is more stable than DHEA — its longer half-life (approximately 7–10 hours versus 15–30 minutes for free DHEA) makes it the preferred biomarker for adrenal androgen status. You don't need to fast for it, and time of day matters less than with cortisol. A single morning blood draw gives a reliable snapshot. If your provider only ordered DHEA (not DHEA-S), ask specifically for the sulfated form — the numbers are different and not interchangeable.

For context on how DHEA-S interacts with other perimenopausal hormones, understanding what a normal estradiol level in perimenopause looks like and what a normal testosterone level in perimenopause looks like helps you see the full adrenal-ovarian picture together.

---

Symptoms That Suggest Your DHEA-S Is Low

Because DHEA-S feeds multiple downstream pathways, the symptom pattern of low levels is wide and nonspecific. Women often describe these symptoms as "everything got worse at once" — which makes it easy to attribute to aging rather than a measurable hormonal shift.

Common presentations include:

• Persistent fatigue that doesn't improve with adequate sleep
• Reduced libido and vaginal dryness not fully explained by low estradiol
• Flattened mood, emotional blunting, or subclinical depression
• Loss of muscle mass and increased central adiposity
• Joint aches and reduced exercise recovery
• Thinning skin, hair shedding, and slowed wound healing
• Difficulty concentrating and word-finding problems

A 12-month placebo-controlled trial of oral DHEA supplementation in women aged 40–70 found statistically significant improvements in well-being scores, sexual function, and lean mass measures in the supplemented group versus placebo, with the largest effect sizes seen in women who started with baseline DHEA-S below 80 µg/dL (Jankowski et al., J Clin Endocrinol Metab 2006; PMID: 16434464). Women who began the trial with DHEA-S already above 150 µg/dL showed minimal measurable gains, reinforcing the point that supplementation is most meaningful when there is genuine deficiency.

---

How Stress and Cortisol Affect DHEA-S During Perimenopause

One of the most underappreciated dynamics of the perimenopausal transition is the cortisol-DHEA-S seesaw. Both hormones share the same upstream precursor — pregnenolone — and both are produced in the adrenal cortex. Under chronic stress, the adrenal glands prioritize cortisol synthesis (sometimes called "cortisol steal" or pregnenolone steal), which leaves less substrate available for DHEA-S production.

This matters enormously in perimenopause because the transition itself is a biological stressor. Fluctuating estrogen sensitizes the HPA axis, making the stress response more reactive. Women navigating sleep disruption, mood instability, and vasomotor symptoms are already running a higher allostatic load — and that allostatic load directly suppresses DHEA-S. The result is a feedback loop: perimenopausal stress reduces DHEA-S, low DHEA-S worsens mood and energy, which increases perceived stress, which further suppresses DHEA-S.

Clinically, this means a woman's DHEA-S level is not a static number — it is partly a readout of her chronic stress burden. Serum cortisol-to-DHEA-S ratio has been proposed as a more useful marker of adrenal health than either hormone alone; ratios above 10:1 (in standard units) are associated with fatigue, immune dysregulation, and poorer mood outcomes in middle-aged women (Heaney et al., Psychoneuroendocrinology 2012; doi:10.1016/j.psyneuen.2012.01.012).

This is why addressing DHEA-S in isolation — without also managing the stress load — often produces underwhelming results. Adaptogenic support that modulates the HPA axis can reduce cortisol output and, over time, allow DHEA-S to recover or respond better to supplementation. Rhodiola rosea, for example, has shown cortisol-lowering effects in randomized trials of adults under chronic occupational stress (Olsson et al., Planta Medica 2009; PMID: 19016404).

---

Should You Take DHEA With Food or on an Empty Stomach?

This is one of the most common practical questions once someone is prescribed or considering DHEA supplementation. The short answer: it likely doesn't matter as much as the dose form and the dose itself.

Oral DHEA has modest but real bioavailability issues — first-pass hepatic metabolism degrades a significant fraction before it reaches systemic circulation. Taking DHEA with a small amount of fat can modestly improve absorption, since DHEA is a lipophilic molecule. However, the clinical trials demonstrating benefit used both fed and fasted protocols without dramatic differences in outcomes, suggesting the timing is a secondary variable.

What matters more:

1. Dose: Most clinical trials showing benefit used 25–50 mg/day. Higher doses (75–100 mg) are used in some protocols but increase the risk of androgenic side effects (acne, oily skin, unwanted hair growth) without proportionally greater hormonal benefit.
2. Form: Micronized DHEA has better absorption than standard crystalline DHEA. Sublingual or topical preparations bypass first-pass metabolism but make serum monitoring less reliable.
3. Morning administration: Because DHEA follows a diurnal pattern (highest in the morning), taking it in the morning mimics the natural curve better and avoids potential interference with sleep architecture.
4. Monitoring: DHEA-S should be re-tested 6–8 weeks after starting supplementation to confirm conversion is occurring and levels are landing in the functional range, not overshooting into supraphysiologic territory.

Note that DHEA is an over-the-counter supplement in the United States but a controlled or prescription substance in Canada, the UK, and Australia. Always consult your healthcare provider before starting, particularly if you have a history of hormone-sensitive conditions.

---

DHEA-S and Related Perimenopausal Lab Markers

DHEA-S rarely tells a complete story on its own. The following related markers help contextualize a DHEA-S result and are worth reviewing alongside it:

For example, if DHEA-S is low but SHBG is also elevated, your free androgen pool is doubly compressed — the adrenals are producing less DHEA-S, and what androgens do circulate are being bound and inactivated. You can read more about what a normal SHBG level in perimenopause looks like and what a normal LH level in perimenopause signals to build out the full hormonal picture.

Ferritin is also worth checking in this context. Low ferritin and low DHEA-S produce an overlapping fatigue-and-brain-fog symptom cluster that can be difficult to attribute without the numbers in front of you — see what a normal ferritin level in perimenopause looks like for the relevant ranges.

---

What This Means for Your Formula

Ones doesn't include DHEA directly — it is a hormone, not a supplement ingredient, and is outside the scope of what a personalized capsule formula can safely deliver without clinical supervision. But the systems that govern DHEA-S production and the downstream effects of low DHEA-S are very much within scope.

Ashwagandha (KSM-66, 600 mg): The most clinically validated adaptogen for HPA axis regulation. In a 60-day randomized controlled trial, KSM-66 ashwagandha at 600 mg/day reduced serum cortisol by 27.9% versus placebo in chronically stressed adults (Chandrasekhar et al., Indian Journal of Psychological Medicine 2012; PMID: 23439798). Lower cortisol output preserves pregnenolone substrate for DHEA-S synthesis — making this the most mechanistically direct ingredient for supporting adrenal androgen levels without administering a hormone directly.

Rhodiola Rosea: Ones includes Rhodiola as an individual active for users whose AI assessment identifies elevated stress burden and HPA axis dysregulation. Its primary mechanism (SHR-5 standardized extract) involves partial modulation of cortisol release at the level of the pituitary, with trials showing statistically significant reductions in burnout symptoms and fatigue scores at 200–400 mg/day (Olsson et al., Planta Medica 2009; PMID: 19016404).

Ones Adrenal Support (proprietary blend): For users whose blood work and symptom profile indicate adrenal involvement — which a low DHEA-S level combined with high perceived stress and fatigue often does — the Adrenal Support System Blend is incorporated into the formula. It is designed to support the adrenal axis through adaptogenic and nutritive ingredients rather than hormone replacement, which keeps the formula safe for long-term use without the monitoring requirements that DHEA supplementation demands.

If your lab results show low DHEA-S alongside elevated cortisol or a high cortisol-to-DHEA-S ratio, Ones' AI practitioner is designed to flag that pattern and build a formula that addresses the upstream cause — adrenal stress load — rather than just the number on the report.

---

Key Takeaways

• A normal DHEA-S level in perimenopause is technically 32–240 µg/dL (ages 45–54), but functional medicine practitioners often target 100–200 µg/dL for symptom relief and optimal tissue support.
• DHEA-S declines 50–70% from peak by the perimenopausal years, and the adrenals are expected to compensate for declining ovarian hormones — which they increasingly cannot do.
• The cortisol-to-DHEA-S ratio is often more informative than DHEA-S alone; chronic stress suppresses DHEA-S production through pregnenolone competition, creating a worsening feedback loop.
• Women with DHEA-S below 80 µg/dL show the greatest measurable benefits from support; those already in the upper range show minimal additional gain from supplementation.
• If supplementing orally, 25–50 mg of micronized DHEA in the morning is the best-supported protocol; recheck DHEA-S levels at 6–8 weeks to confirm appropriate conversion.
• DHEA-S should always be interpreted alongside estradiol, testosterone, SHBG, LH, and cortisol — no single marker tells the full perimenopausal story.